Novel Therapies and Monitoring in Cholestatic Disease

Description

This abstract parallel session features a series of reports on the exploration of new agents in AIH and PBC, along with intriguing data on enhanced monitoring in cholestatic disorders.  

Objectives

  • Describe the complexities and options for AIH treatments.
  • Discuss the potential roles for PPAR modulation in PBC.
  • Identify the potential roles for IBAT targeting in cholestasis.